In the normal samples, the expression of HMGCS2 was higher in breast invasive carcinoma (BRCA), head and neck squamous cell carcinoma (HNSCC), kidney chromophobe (KICH), kidney renal clear cell carcinoma (KIRC), kidney renal papillary cell carcinoma (KIRP), SKCM and TGCTs (Figure 7F). This evidence concerns the gene HMGCS2 and invasive breast carcinoma.